Home / Deep Research / Pontiac Fever

Pontiac Fever

1. Disease Information

2026-05-06
Falcon MONDO:0020487 Model: Edison Scientific Literature 19 citations

1. Disease Information

1.1 Overview (what is Pontiac fever?)

Pontiac fever is the non-pneumonic (no pneumonia) and typically self-limited, influenza-like clinical form of legionellosis caused by Legionella spp. (sylvestre2023module16legionella pages 10-14, khairullah2025legionnaires’diseasea pages 4-6, piedade2020analysisoflegionellas pages 30-33). In practical surveillance and outbreak settings, Pontiac fever is frequently recognized as clusters of acute febrile illness after a shared environmental exposure rather than as sporadic, individually diagnosed illness, because mild cases may not seek care and diagnostic approaches are often geared toward pneumonia. (currie2023theecologyof pages 20-23, hamilton2018outbreaksoflegionnaires’ pages 2-4)

Abstract-supported definition (direct quote): A hospital-based epidemiology paper explicitly frames the two forms of disease as: “pneumonic legionnaires’ disease and non-pneumonic legionnaires’ disease (Pontiac fever)” (kosinska2018useofhospital pages 1-2).

1.2 Key identifiers

1.3 Synonyms / alternative names

1.4 Evidence type note (individual vs aggregated)

Evidence available in this retrieval set is primarily aggregated (outbreak reviews; administrative hospital datasets; surveillance methodology and environmental control guidance), rather than prospective, patient-level clinical cohorts. (hamilton2018outbreaksoflegionnaires’ pages 2-4, wade2024weatherconditionsand pages 2-3, kosinska2018useofhospital pages 1-2)

2. Etiology

2.1 Disease causal factors

Pontiac fever is caused by exposure to pathogenic Legionella bacteria, typically via inhalation of contaminated aerosols generated from built-environment water systems (e.g., cooling towers, spas, fountains, building water distribution systems). (sylvestre2023module16legionella pages 10-14, hamilton2018outbreaksoflegionnaires’ pages 2-4)

2.2 Infectious agents implicated

While Legionella pneumophila is often the dominant species in reported legionellosis, Pontiac-fever outbreaks can involve multiple species, including non-pneumophila species. - Reported Pontiac-fever–associated species in the retrieved evidence include: L. pneumophila, L. anisa, L. micdadei, L. feeleii, L. longbeachae. (currie2023theecologyof pages 17-20, piedade2020analysisoflegionellas pages 30-33) - A Legionella ecology review notes the genus includes “>72 species” and that “at least 30 species are known to cause human infections,” with most reported cases attributed to L. pneumophila. (sylvestre2023module16legionella pages 10-14)

2.3 Risk factors

Pontiac fever risk is dominated by environmental exposure intensity and conditions favoring Legionella growth and aerosolization.

Environmental/built environment risk factors: - Colonization of man-made water systems, where growth is favored by warm temperatures, stagnation, biofilms, nutrients, and low disinfectant levels. (sylvestre2023module16legionella pages 10-14) - Temperature dependence: growth favored around 25–43°C, with an “optimal 30–40°C,” and die-off above ~60°C. (sylvestre2023module16legionella pages 10-14)

Exposure setting risk factors (outbreak-relevant): A large outbreak review (2006–2017) showed most reported Pontiac-fever outbreak cases were associated with engineered water/aerosol sources (Table 1 image). (hamilton2018outbreaksoflegionnaires’ media e7cee3af)

Host factors: In the retrieved evidence, Pontiac fever is described as not strongly discriminating by age or immune status compared with Legionnaires’ disease (suggesting broader susceptibility once exposed), although rigorous comparative risk estimates were not available. (currie2023theecologyof pages 17-20)

2.4 Protective factors

Protective factors were not directly quantified for Pontiac fever in the retrieved literature. Preventive measures are largely environmental (see Prevention section). (sylvestre2023module16legionella pages 10-14)

2.5 Gene–environment interactions

No host genetic susceptibility loci, causal variants, or modifier genes were identified in the retrieved evidence; Pontiac fever is best supported here as an environmentally acquired infectious syndrome. (currie2023theecologyof pages 17-20, graham2024astudyofa pages 134-137)

3. Phenotypes

3.1 Core clinical phenotype (symptoms/signs)

Pontiac fever typically presents as an influenza-like illness with: - Fever (sylvestre2023module16legionella pages 10-14, khairullah2025legionnaires’diseasea pages 4-6) - Headache (sylvestre2023module16legionella pages 10-14, currie2023theecologyof pages 17-20, khairullah2025legionnaires’diseasea pages 4-6) - Myalgia/muscle aches (sylvestre2023module16legionella pages 10-14, currie2023theecologyof pages 17-20, khairullah2025legionnaires’diseasea pages 4-6) - Malaise/lethargy (currie2023theecologyof pages 17-20, khairullah2025legionnaires’diseasea pages 4-6) - Dry cough (reported in building-water guidance) (sylvestre2023module16legionella pages 10-14)

3.2 Phenotype characteristics

3.3 Timing

3.4 Quality of life impact

No validated quality-of-life metrics (e.g., EQ-5D, SF-36) specific to Pontiac fever were identified in the retrieved evidence. (hamilton2018outbreaksoflegionnaires’ pages 2-4)

3.5 Suggested HPO terms (phenotype ontology)

Suggested mapping (terms provided as suggestions; IDs not validated within this tool run): - Fever (HP:0001945) - Headache (HP:0002315) - Myalgia (HP:0003326) - Malaise/Fatigue (HP:0012378 / HP:0012378-like) - Cough (HP:0012735)

4. Genetic / Molecular Information

4.1 Causal genes and pathogenic variants

Not applicable based on retrieved evidence. Pontiac fever is not supported here as a Mendelian/genetic disorder, and no host causal gene/variant associations were identified. (currie2023theecologyof pages 17-20, graham2024astudyofa pages 134-137)

4.2 Pathogen-side molecular context (relevant to diagnostics and surveillance)

A major molecular diagnostic limitation is that the commonly used urinary antigen test (UAT) detects only L. pneumophila serogroup 1, creating a “blind spot” for other species/serogroups that can cause legionellosis and potentially Pontiac-fever outbreaks. (hamilton2018outbreaksoflegionnaires’ pages 2-4, graham2024astudyofa pages 134-137)

5. Environmental Information

5.1 Environmental factors

Key environmental factors include colonization of engineered water systems and conditions enabling aerosol generation. - Reservoirs and sources include cooling towers, hot tubs/spas, fountains, and building water distribution systems. (sylvestre2023module16legionella pages 10-14, hamilton2018outbreaksoflegionnaires’ pages 2-4) - Legionella ecology includes natural aquatic habitats and association with biofilms and likely protozoan hosts (not fully elaborated for PF in this evidence set). (sylvestre2023module16legionella pages 10-14, currie2023theecologyof pages 20-23)

5.2 Lifestyle factors

No direct lifestyle risk factors for Pontiac fever were quantified in the retrieved evidence; lifestyle risks are more often discussed for Legionnaires’ disease (e.g., smoking), not specifically for PF. (khairullah2025legionnaires’diseasea pages 2-3)

5.3 Infectious agents

6. Mechanism / Pathophysiology

6.1 Current mechanistic understanding

A mechanistic hypothesis described in a 2023 ecology-focused review distinguishes Pontiac fever from Legionnaires’ disease: Pontiac fever may represent a hypersensitivity/inflammatory response to an “unknown bacterial/amoebal-host component,” rather than an invasive infection with intracellular replication typical of Legionnaires’ disease. (currie2023theecologyof pages 17-20)

6.2 Causal chain (trigger → symptoms)

  1. Upstream trigger: aerosol exposure to Legionella-containing droplets from colonized water systems (cooling towers, spas, etc.). (sylvestre2023module16legionella pages 10-14, hamilton2018outbreaksoflegionnaires’ pages 2-4)
  2. Intermediate steps: short incubation (often 24–48 h) consistent with a brisk inflammatory response. (sylvestre2023module16legionella pages 10-14, khairullah2025legionnaires’diseasea pages 4-6)
  3. Downstream manifestation: systemic flu-like symptoms (fever, headache, myalgia, malaise), typically without pneumonia and self-resolving. (sylvestre2023module16legionella pages 10-14, piedade2020analysisoflegionellas pages 30-33)

6.3 Suggested GO and CL terms (mechanism annotation)

Suggested (not validated in this run): - GO:0006954 inflammatory response - GO:0006955 immune response - GO:0032496 response to lipopolysaccharide (relevant for Gram-negative exposures, hypothesis-level) - CL:0000540 macrophage (relevant in legionellosis generally; PF-specific cell evidence not identified) (currie2023theecologyof pages 17-20)

7. Anatomical Structures Affected

Pontiac fever is primarily a systemic febrile illness after respiratory exposure; unlike Legionnaires’ disease it is non-pneumonic. - Primary system involved: respiratory exposure route (inhalation of aerosols), with systemic symptoms. (sylvestre2023module16legionella pages 10-14, piedade2020analysisoflegionellas pages 30-33) - Suggested UBERON terms (not validated in this run): lung (UBERON:0002048) as exposure/portal; respiratory tract (UBERON:0000065).

8. Temporal Development

9. Inheritance and Population

9.1 Epidemiology and outbreak statistics

Pontiac fever is mainly characterized in the literature through outbreaks; surveillance and case definitions are inconsistent.

No universal case definition: A major outbreak review states that “there is currently no agreed-upon case definition for Pontiac fever.” (hamilton2018outbreaksoflegionnaires’ pages 2-4)

Outbreak burden (2006–2017): A review of outbreaks reported 725 Pontiac fever cases in the period 2006–2017. (hamilton2018outbreaksoflegionnaires’ pages 2-4)

Outbreak sources: The same review provides source-specific totals, showing Pontiac-fever cases were mostly associated with pools/spas and aerosol-generating systems; these data are summarized in Table 1 (image). (hamilton2018outbreaksoflegionnaires’ media e7cee3af)

Attack rate: Pontiac fever is described as having a very high attack rate in outbreak settings, reported “up to 100% of those exposed,” and another review excerpt cites PF sources where “>90% become ill” contrasted with LD sources “<5%.” (currie2023theecologyof pages 17-20, piedade2020analysisoflegionellas pages 30-33)

9.2 Demographics (from administrative datasets)

PF-specific demographic statistics are sparse; however, legionellosis hospitalization datasets provide context: - US Medicare hospitalization case-crossover study (1999–2020): 37,883 legionellosis hospitalizations (after exclusions), 58% male, median age 73 (range 13–106); authors caution that few PF-only cases existed in this dataset, limiting PF-specific inference. (wade2024weatherconditionsand pages 2-3) - Poland hospital morbidity analysis (2008–2015): 84 first-time hospitalizations coded as A48.1/A48.2, more frequent in men and urban residents; mean hospital stay 14.68 days (this largely reflects hospitalized legionellosis, not necessarily typical PF). (kosinska2018useofhospital pages 1-2)

9.3 Inheritance

Not applicable (infectious disease; no genetic inheritance pattern identified). (currie2023theecologyof pages 17-20)

10. Diagnostics

10.1 Clinical approach

Pontiac fever is often diagnosed by: - compatible clinical syndrome (acute flu-like illness, no pneumonia), - short incubation after a shared exposure, - and outbreak linkage to Legionella-contaminated sources. (hamilton2018outbreaksoflegionnaires’ pages 2-4)

10.2 Laboratory testing

Tests used in legionellosis outbreak investigations include: - Urinary antigen test (UAT) (limited to L. pneumophila serogroup 1) (hamilton2018outbreaksoflegionnaires’ pages 2-4, graham2024astudyofa pages 134-137) - Serology (e.g., IFA/ELISA) (hamilton2018outbreaksoflegionnaires’ pages 2-4) - Culture (may have poor sensitivity) (graham2024astudyofa pages 134-137) - PCR/NAAT (broader detection; increasing adoption) (currie2023theecologyof pages 20-23, graham2024astudyofa pages 134-137)

Diagnostic blind spot: reliance on UAT biases detection toward L. pneumophila serogroup 1 and may under-detect non-pneumophila species that can be associated with Pontiac fever. (currie2023theecologyof pages 20-23, graham2024astudyofa pages 134-137)

10.3 Environmental testing

Environmental sampling and linkage of clinical and environmental isolates is a common outbreak method; one outbreak review reported matching of clinical and environmental isolates in ~35% of outbreaks. (hamilton2018outbreaksoflegionnaires’ pages 2-4)

11. Outcome / Prognosis

Pontiac fever is typically self-resolving and not associated with mortality in the retrieved evidence. (piedade2020analysisoflegionellas pages 30-33)

12. Treatment

12.1 Standard care

Pontiac fever generally requires supportive/symptomatic care only, and “most affected people recover within a week and usually do not require medical treatment.” (sylvestre2023module16legionella pages 10-14, piedade2020analysisoflegionellas pages 30-33)

12.2 Antibiotics

Antibiotics (e.g., macrolides, fluoroquinolones) are commonly discussed for Legionnaires’ disease and severe legionellosis; their routine use for typical Pontiac fever is not supported in the retrieved evidence, given self-limited course. (hongUnknownyearthebodysystem pages 12-21, piedade2020analysisoflegionellas pages 30-33)

12.3 Suggested MAXO terms (treatment/prevention action ontology)

Suggested (not validated in this run): - Supportive care (MAXO:0000747-like) - Symptomatic treatment (MAXO:0000746-like) - Environmental disinfection / water system remediation (MAXO terms likely exist but not retrieved here)

13. Prevention

Prevention of Pontiac fever aligns with prevention of legionellosis generally and is centered on water management and aerosol source control.

13.1 Primary prevention (built environment)

A 2023 guide for building managers/operators emphasizes that Legionella colonizes engineered water systems and that growth is promoted by warm temperatures, biofilms, stagnation, and low disinfectant levels; controlling these conditions is fundamental to prevention. (sylvestre2023module16legionella pages 10-14)

Practical control levers include: - Temperature control (keeping hot water sufficiently hot; thresholds discussed in environmental contexts) (sylvestre2023module16legionella pages 10-14) - Reducing stagnation and maintaining flow (sylvestre2023module16legionella pages 10-14) - Biofilm control and maintaining disinfectant residuals (sylvestre2023module16legionella pages 10-14)

13.2 Secondary/tertiary prevention (outbreak response)

Outbreak investigations commonly use clinical case finding plus environmental investigation and targeted remediation of implicated sources (e.g., cooling towers/spas) as documented in outbreak-review contexts. (hamilton2018outbreaksoflegionnaires’ pages 2-4)

14. Other Species / Natural Disease

No naturally occurring Pontiac-fever syndrome in non-human species was identified in the retrieved evidence. (currie2023theecologyof pages 17-20)

15. Model Organisms

Pontiac-fever–specific experimental models were not identified in the retrieved evidence. However, Legionella research broadly uses host–pathogen systems (e.g., protozoa and mammalian phagocytes) to study mechanisms of infection and host interaction; PF-specific translation of these models was not established in the retrieved set. (currie2023theecologyof pages 17-20)

Recent developments and latest research (prioritizing 2023–2024)

  1. Surveillance and coding improvements: A 2024 New Zealand analysis explicitly uses ICD-10 coding (A48.1/A48.2) and discusses diagnostic evolution and limitations of culture and urinary antigen testing, with increasing use of NAAT/PCR; this is directly relevant to recognizing under-detected, non-pneumonic presentations such as Pontiac fever. (graham2024astudyofa pages 134-137, graham2024astudyof pages 134-137)
  2. Weather/climate associations (context for legionellosis trends): A large 2024 US Medicare analysis (37,883 hospitalizations) links precipitation/humidity to legionellosis hospitalization risk at lags consistent with incubation; while not PF-specific, it supports the broader environmental sensitivity of Legionella disease risk. (wade2024weatherconditionsand pages 2-3)
  3. Built-environment implementation guidance (2023): Practical building water system control guidance provides operationally relevant parameters (growth temperature ranges; system types implicated) and provides accessible definitions of Pontiac fever for non-clinical stakeholders managing risk. (sylvestre2023module16legionella pages 10-14)

Key quantitative data highlights

Evidence summary table

Table (click to expand)
Domain Key points Quantitative/statistical data Key sources (with citation ids) URLs/publication dates if in evidence
Definition / current understanding Pontiac fever is the non-pneumonic, acute, self-limited influenza-like form of legionellosis caused by Legionella spp.; unlike Legionnaires’ disease, pneumonia is absent. Recognition is often outbreak-based because mild cases may be missed. Illness duration usually 2–5 days or recovery within about 1 week; no mortality typically expected in uncomplicated cases. (sylvestre2023module16legionella pages 10-14, khairullah2025legionnaires’diseasea pages 4-6, currie2023theecologyof pages 20-23, piedade2020analysisoflegionellas pages 30-33) Sylvestre & Julian, 2023; Khairullah et al., Mar 2025, https://doi.org/10.14202/ijoh.2025.62-77; Piedade, 2020
Identifiers / codes Standardized coding is available at the disease-group level as non-pneumonic legionellosis. ICD-10 code A48.2 is used for Pontiac fever; ICD-10 A48.1 is Legionnaires’ disease. Earlier ICD-9 datasets often lacked a distinct PF code, complicating surveillance. No explicit ICD-11 or MeSH identifier was found in the retrieved evidence. ICD-10: A48.2 (Pontiac fever); A48.1 (Legionnaires’ disease). (graham2024astudyofa pages 134-137, wade2024weatherconditionsand pages 2-3, kosinska2018useofhospital pages 1-2) Wade & Herbert, Oct 2024, https://doi.org/10.1017/S0950268824000979; Kosińska et al., Dec 2018, https://doi.org/10.26444/monz/101676
Clinical characteristics Typical symptoms include fever, headache, myalgia, malaise/lethargy, and often dry cough; disease is mild to moderate and self-resolving. Average incubation 24–48 h; can be described more broadly as hours to several days; symptoms usually last 2–5 days, with most recovering within 1 week. (sylvestre2023module16legionella pages 10-14, currie2023theecologyof pages 17-20, khairullah2025legionnaires’diseasea pages 4-6, piedade2020analysisoflegionellas pages 30-33) Sylvestre & Julian, 2023; Khairullah et al., Mar 2025, https://doi.org/10.14202/ijoh.2025.62-77; Piedade, 2020
Attack rate / severity PF is epidemiologically distinct from Legionnaires’ disease by its very high attack rate and low severity; many exposed persons may become ill, but illness is usually not life-threatening. Attack rate reported as up to 100% among exposed persons; CDC-sourced comparison cited in one review: PF sources >90% ill vs LD sources <5%. (currie2023theecologyof pages 17-20, piedade2020analysisoflegionellas pages 30-33) Currie, 2023; Piedade, 2020
Etiology / infectious agents Caused by Legionella species; L. pneumophila is the dominant species overall, but PF outbreaks have also involved non-pneumophila species. Reported PF-associated species include L. anisa, L. micdadei, L. feeleii, and L. longbeachae. Legionella genus noted as >72 species overall; at least 30 species known to cause human infection; most reported human cases attributed to L. pneumophila. (sylvestre2023module16legionella pages 10-14, currie2023theecologyof pages 17-20, piedade2020analysisoflegionellas pages 30-33, hamilton2018outbreaksoflegionnaires’ pages 2-4) Sylvestre & Julian, 2023; Hamilton et al., May 2018, https://doi.org/10.1007/s40572-018-0201-4
Exposure sources / real-world settings Exposure is primarily environmental through inhalation of contaminated aerosols from engineered water systems; non-pneumophila disease can also follow exposure to soil/compost or dust. Common sources include cooling towers, pools/spas/hot tubs, fountains, potable building water systems, wastewater systems, and gardening/potting soils for L. longbeachae. No person-to-person transmission evidence was identified in the retrieved PF-focused evidence. Outbreak review 2006–2017 recorded PF cases by source: pools/spas 433; cooling towers/AC/evaporative condensers 146; non-potable water systems 139; potable/building water systems 7. (sylvestre2023module16legionella pages 10-14, khairullah2025legionnaires’diseasea pages 4-6, currie2023theecologyof pages 20-23, hamilton2018outbreaksoflegionnaires’ pages 2-4, hamilton2018outbreaksoflegionnaires’ media e7cee3af) Hamilton et al., May 2018, https://doi.org/10.1007/s40572-018-0201-4; Sylvestre & Julian, 2023
Environmental growth factors Legionella is naturally aquatic and colonizes man-made water systems; growth is promoted by warm water, stagnation, biofilms, nutrients, and inadequate disinfectant residuals. Growth favored at 25–43°C; optimal 30–40°C; die-off above 60°C. Warm-water reservoir often described as 25–40°C. (sylvestre2023module16legionella pages 10-14, hongUnknownyearthebodysystem pages 12-21) Sylvestre & Julian, 2023
Pathophysiology / expert analysis Evidence supports PF as a host inflammatory/hypersensitivity-like response to Legionella or amoebal-host components rather than the invasive intracellular replication pattern typical of Legionnaires’ disease. This explains short incubation, high attack rate, and absence of pneumonia. Qualitative rather than numeric; proposed mechanism distinguishes PF from LD. (currie2023theecologyof pages 17-20) Currie, 2023
Epidemiology / burden PF is underrecognized because surveillance emphasizes pneumonia and urinary antigen testing; sporadic PF is likely substantially underdetected. Outbreak summaries provide the clearest counts. International outbreak review (2006–2017): 725 PF cases identified; no universally agreed PF case definition noted in that review. (hamilton2018outbreaksoflegionnaires’ pages 2-4, hamilton2018outbreaksoflegionnaires’ media e7cee3af) Hamilton et al., May 2018, https://doi.org/10.1007/s40572-018-0201-4
Demographics / distribution Legionellosis overall shows male predominance, older age skew for hospitalization datasets, summer seasonality, and urban concentration in some datasets; PF-specific demographic data are much sparser. Medicare legionellosis hospital dataset: 37,883 cases after exclusions, 58% male, median age 73 years; Poland hospital dataset: 84 first-time hospitalizations with male and urban predominance and summer peak. (wade2024weatherconditionsand pages 2-3, kosinska2018useofhospital pages 1-2) Wade & Herbert, Oct 2024, https://doi.org/10.1017/S0950268824000979; Kosińska et al., Dec 2018, https://doi.org/10.26444/monz/101676
Diagnostics PF diagnosis is mainly clinical plus exposure/outbreak context; tests used across legionellosis investigations include urinary antigen testing, serology, culture, PCR/NAAT, and epidemiologic linkage. UAT is a major surveillance blind spot because it detects only L. pneumophila serogroup 1. PCR/culture improve breadth of detection; PF may be missed if only UAT is used. UAT used in 88.6% of European legionellosis cases in one cited discussion; PCR implementation associated with a fourfold increase in detection in one review excerpt. Matching clinical/environmental isolates occurred in ~35% of outbreaks. (currie2023theecologyof pages 17-20, currie2023theecologyof pages 20-23, hamilton2018outbreaksoflegionnaires’ pages 2-4, graham2024astudyofa pages 134-137) Hamilton et al., May 2018, https://doi.org/10.1007/s40572-018-0201-4; Wade & Herbert, Oct 2024, https://doi.org/10.1017/S0950268824000979
Case definitions There is no universally agreed PF case definition in the outbreak review literature; surveillance case definitions have evolved over time and differ by jurisdiction. Review explicitly states no agreed-upon PF case definition; NZ surveillance criteria historically relied on serology, DFA, or isolation. (hamilton2018outbreaksoflegionnaires’ pages 2-4, graham2024astudyofa pages 81-84) Hamilton et al., May 2018, https://doi.org/10.1007/s40572-018-0201-4
Treatment / management Standard management is supportive/symptomatic care; most patients do not require specific antimicrobial therapy. Antibiotics listed in legionellosis guidance (macrolides, fluoroquinolones) are mainly for Legionnaires’ disease or severe invasive infection rather than typical PF. Recovery without treatment is typical; supportive care only in uncomplicated PF. (sylvestre2023module16legionella pages 10-14, currie2023theecologyof pages 20-23, piedade2020analysisoflegionellas pages 30-33) Sylvestre & Julian, 2023; Piedade, 2020
Prevention / public health implementation Prevention focuses on source control in building and environmental water systems: water management programs, temperature control, minimizing stagnation, biofilm control, maintaining disinfectant residuals, regular monitoring, corrective actions during outbreaks, and special attention to high-risk sources such as pools/spas, cooling towers, hot-water systems, and wastewater processes. For L. longbeachae risk, avoiding inhalation of dust/aerosols from potting soil/compost and use of masks/gloves are advised, though effectiveness evidence is limited. Facilities without water management programs accounted for 72% of LD cases and 81% of fatalities in one CDC-led outbreak root-cause analysis (legionellosis control relevance). Tap temperatures >54°C and central tank temperatures >59°C were associated with lower Legionella levels in one recent school-water study. (sylvestre2023module16legionella pages 10-14, hongUnknownyearthebodysystem pages 12-21, currie2023theecologyof pages 20-23) Sylvestre & Julian, 2023; Nielsen et al., Oct 2024, https://doi.org/10.3390/microorganisms12102074
Recent developments (2023–2024) Recent work emphasizes environmental surveillance, broader molecular diagnostics beyond UAT, climate/weather associations, and built-environment risk modeling. These developments are directly relevant to PF recognition because PF is often missed in pneumonia-centered surveillance systems. 2024 Medicare weather study: 37,883 legionellosis hospitalizations; precipitation at lag day 10 OR 1.08 (95% CI 1.05–1.11) per 1 cm; over 20 days, 3 cm precipitation increased odds >4-fold for legionellosis hospitalizations. (wade2024weatherconditionsand pages 2-3, graham2024astudyof pages 134-137) Wade & Herbert, Oct 2024, https://doi.org/10.1017/S0950268824000979; Graham, 2024
Data limitations Many PF data derive from aggregated outbreak investigations rather than individual patient-level natural history cohorts; PF-specific prevalence/incidence, QoL, genetic susceptibility, biomarkers, and formal ontology mappings were not available in the retrieved evidence. Surveillance underascertainment likely substantial because mild cases may not seek care and UAT misses many non-LpSG1 infections. (currie2023theecologyof pages 17-20, hamilton2018outbreaksoflegionnaires’ pages 2-4, graham2024astudyofa pages 134-137) Hamilton et al., May 2018, https://doi.org/10.1007/s40572-018-0201-4; Graham, 2024

Table: This table consolidates the most actionable evidence on Pontiac fever across clinical presentation, coding, causative species, exposure settings, diagnostics, management, prevention, and recent epidemiologic findings. It is useful as a compact knowledge-base-ready summary grounded in the cited evidence contexts.

Supporting visual evidence

A key summary table of outbreak sources and case counts (Pontiac fever and Legionnaires’ disease, 2006–2017) is provided as a cropped figure. (hamilton2018outbreaksoflegionnaires’ media e7cee3af)

References

  1. (graham2024astudyofa pages 134-137): FF Graham. A study of legionellosis epidemiology and alternative environmental risk factors for the disease in new zealand. Unknown journal, 2024.

  2. (sylvestre2023module16legionella pages 10-14): É Sylvestre and TR Julian. Module 16 legionella control in building water systems: a guide for building managers and operators. Unknown journal, 2023.

  3. (khairullah2025legionnaires’diseasea pages 4-6): Aswin Rafif Khairullah, Harimurti Nuradji, Diana Nurjanah, Ni Luh Putu Indi Dharmayanti, Bantari Wisynu Kusuma Wardhani, Syahputra Wibowo, Ikechukwu Benjamin Moses, Dea Anita Ariani Kurniasih, Ima Fauziah, Muhammad Khaliim Jati Kusala, and Kartika Afrida Fauzia. Legionnaires’ disease: a review of emerging public health threats. International Journal of One Health, pages 62-77, Mar 2025. URL: https://doi.org/10.14202/ijoh.2025.62-77, doi:10.14202/ijoh.2025.62-77. This article has 2 citations.

  4. (piedade2020analysisoflegionellas pages 30-33): SBL Piedade. Analysis of legionella's presence and concentration in water systems control. Unknown journal, 2020.

  5. (currie2023theecologyof pages 20-23): S Currie. The ecology of legionella spp in compost. Unknown journal, 2023.

  6. (hamilton2018outbreaksoflegionnaires’ pages 2-4): K. A. Hamilton, A. J. Prussin, W. Ahmed, and C. N. Haas. Outbreaks of legionnaires’ disease and pontiac fever 2006–2017. Current Environmental Health Reports, 5:263-271, May 2018. URL: https://doi.org/10.1007/s40572-018-0201-4, doi:10.1007/s40572-018-0201-4. This article has 118 citations and is from a peer-reviewed journal.

  7. (kosinska2018useofhospital pages 1-2): Irena Kosińska, Aneta Nitsch-Osuch, Krzysztof Kanecki, Paweł Goryński, and Piotr Tyszko. Use of hospital morbidity data in an epidemiological analysis of diseases caused by legionella pneumophila. Medycyna Ogólna i Nauki o Zdrowiu, 24:251-256, Dec 2018. URL: https://doi.org/10.26444/monz/101676, doi:10.26444/monz/101676. This article has 2 citations.

  8. (wade2024weatherconditionsand pages 2-3): Timothy J. Wade and Carly Herbert. Weather conditions and legionellosis: a nationwide case-crossover study among medicare recipients. Epidemiology and Infection, Oct 2024. URL: https://doi.org/10.1017/s0950268824000979, doi:10.1017/s0950268824000979. This article has 7 citations and is from a peer-reviewed journal.

  9. (currie2023theecologyof pages 17-20): S Currie. The ecology of legionella spp in compost. Unknown journal, 2023.

  10. (hamilton2018outbreaksoflegionnaires’ media e7cee3af): K. A. Hamilton, A. J. Prussin, W. Ahmed, and C. N. Haas. Outbreaks of legionnaires’ disease and pontiac fever 2006–2017. Current Environmental Health Reports, 5:263-271, May 2018. URL: https://doi.org/10.1007/s40572-018-0201-4, doi:10.1007/s40572-018-0201-4. This article has 118 citations and is from a peer-reviewed journal.

  11. (khairullah2025legionnaires’diseasea pages 2-3): Aswin Rafif Khairullah, Harimurti Nuradji, Diana Nurjanah, Ni Luh Putu Indi Dharmayanti, Bantari Wisynu Kusuma Wardhani, Syahputra Wibowo, Ikechukwu Benjamin Moses, Dea Anita Ariani Kurniasih, Ima Fauziah, Muhammad Khaliim Jati Kusala, and Kartika Afrida Fauzia. Legionnaires’ disease: a review of emerging public health threats. International Journal of One Health, pages 62-77, Mar 2025. URL: https://doi.org/10.14202/ijoh.2025.62-77, doi:10.14202/ijoh.2025.62-77. This article has 2 citations.

  12. (hongUnknownyearthebodysystem pages 12-21): A Hong. The body system in legionellosis. Unknown journal, Unknown year.

  13. (graham2024astudyof pages 134-137): FF Graham. A study of legionellosis epidemiology and alternative environmental risk factors for the disease in new zealand. Unknown journal, 2024.

  14. (graham2024astudyofa pages 81-84): FF Graham. A study of legionellosis epidemiology and alternative environmental risk factors for the disease in new zealand. Unknown journal, 2024.